ArticleEuropean journal of public health2012
Incidence and 30-day case fatality for acute myocardial infarction in England in 2010: national-linked database study.
Article in European journal of public health, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it, 59 citations in OpenAlex.
- Motivational support intervention to reduce smoking and increase physical activity in smokers not ready to quit: the TARS RCT.Health technology assessment (Winchester, England) · 2023Pooled it
- Incidence of Acute Myocardial Infarction in Hungary: A Nationwide Study.Journal of clinical medicine · 2026Article
- Diagnostic accuracy, treatment and prognosis of myocardial infarction: an 11-year follow-up of a community-based cohort of 0.5 million Chinese adults.BMJ public health · 2026Article
- Risk prediction in people with acute myocardial infarction in England: a cohort study using data from 1521 general practices.BMJ open · 2025Article
- Comparison of all-cause and cause-specific mortality after myocardial infarction - a Hungarian registry study.American heart journal plus : cardiology research and practice · 2025Article
- Health economic analysis of polygenic risk score use in primary prevention of coronary artery disease - A system dynamics model.American journal of preventive cardiology · 2024Article
- Arterial Thromboembolism in Cancer Patients: A Danish Population-Based Cohort Study.JACC. CardioOncology · 2021Article
- Real-world cost-effectiveness of rivaroxaban and apixaban vs VKA in stroke prevention in non-valvular atrial fibrillation in the UK.Journal of market access & health policy · 2020Article
- The effect of the look-back period for estimating incidence using administrative data.BMC health services research · 2020Article
- PRIMEtime CE: a multistate life table model for estimating the cost-effectiveness of interventions affecting diet and physical activity.BMC health services research · 2019Article
- A Discrete Event Simulation Model to Assess the Economic Value of a Hypothetical Pharmacogenomics Test for Statin-Induced Myopathy in Patients Initiating a Statin in Secondary Cardiovascular Prevention.Molecular diagnosis & therapy · 2018Article
- The polypill approach - An innovative strategy to improve cardiovascular health in Europe.BMC pharmacology & toxicology · 2017Review
- Assessing the external validity of model-based estimates of the incidence of heart attack in England: a modelling study.BMC public health · 2016Article
- The impact of social deprivation on mortality following acute myocardial infarction, stroke or subarachnoid haemorrhage: a record linkage study.BMC cardiovascular disorders · 2015Article
- Article
- A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys.The lancet. Diabetes & endocrinology · 2015 · on this mapArticle
- Clinical disease registries in acute myocardial infarction.World journal of cardiology · 2014Review
- Primary preventive potential of major lifestyle risk factors for acute myocardial infarction in men: an analysis of the EPIC-Heidelberg cohort.European journal of epidemiology · 2014Article
- Adapting and validating diabetes simulation models across settings: accounting for mortality differences using administrative data.Journal of diabetes and its complicationsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
Abstract
backgroundThere are limited national population-based epidemiological data on acute myocardial infarction (AMI) in England, making the current burden of disease, and clinical prognosis, difficult to quantify. The aim of this study was to provide national estimates of incidence and 30-day case fatality rate (CFR) for first and recurrent AMI in England.
methodsPopulation-based study using person-linked routine hospital and mortality data on 79 896 individuals of any age, who were admitted to hospital for AMI or who died suddenly from AMI in 2010.
resultsOf 82 252 AMI events in 2010, 83% were first. Age-standardized incidence of first AMI per 100 000 population was 130 (95% CI 129-131) in men and 55.9 (95% CI 55.3-56.6) in women. Age-standardized 30-day overall CFRs including sudden AMI deaths for men and women, respectively, were 32.4% (95% CI 32.0-32.9) and 30.3% (95% CI 29.8-30.9) for first AMI and 29.7% (95% CI 28.7-30.7) and 26.7% (95% CI 25.5-27.9) for recurrent AMI. Age-standardized hospitalized 30-day CFR was 12.0% (95% CI 11.6-12.3) for men and 12.3% (95% CI 11.9-12.7) for women.
conclusionsWhile the majority of AMIs are not fatal, of those that are, two-thirds occur as sudden AMI deaths. About one in six of all AMIs are recurrent events. These findings reinforce the importance of primary and secondary prevention in reducing AMI morbidity and mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.